Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

33.68 -3.49 (-9.39%)

Official Closing Price Updated: 4:10 PM EDT, Jul 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

1 Stock Under $50 with Exciting Potential and 2 Facing Challenges

July 13, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

Via The Motley Fool

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗

July 06, 2026

Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.

Via MarketBeat

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 01, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an annualized basis producing an average annual return of 28.89%. Currently, Hims & Hers Health has a...

Via Benzinga

Hims & Hers Stock Surges as Analysts Lift Price Targets ↗

July 01, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Canaccord Genuity raised their respective price targets on the stock.

Via Benzinga

Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today ↗

June 23, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an annualized basis producing an average annual return of 25.67%. Currently, Hims & Hers Health has a...

Via Benzinga

June 23, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

1 Surging Stock Worth Your Attention and 2 We Find Risky

June 22, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

Topics Supply Chain

Hims & Hers Stock Jumps After Barclays Raises Price Target ↗

June 18, 2026

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target from $29 to $39.

Via Benzinga

Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know ↗

June 16, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher on Tuesday as the stock continues to rebound from recent profit-taking.

Via Benzinga

3 Market-Beating Stocks with Exciting Potential

June 16, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock ↗

June 05, 2026

This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic?

Via The Motley Fool

1 Growth Stock Set to Flourishand 2 We Ignore

June 04, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Topics Economy

2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds

June 02, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Is Hims & Hers Stock an Undervalued Stock to Buy? ↗

June 01, 2026

The healthcare industry is ripe for disruption.

Via The Motley Fool

Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗

May 28, 2026

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

Via MarketBeat

Topics Earnings

Hims & Hers Shares Rally On Million-Dollar Insider Purchase ↗

May 27, 2026

Shares of Hims & Hers Health Inc (NYSE: HIMS) are trading higher Wednesday morning after insider stock purchase boosts investor confidence.

Via Benzinga

The Silver Lining of Last Week's Hims & Hers Earnings Miss ↗

May 21, 2026

Hims & Hers plunged 23% after a major Q1 earnings miss, but long-term growth stays intact via its Novo Nordisk GLP-1 partnership and a late 2026 expansion.

Via MarketBeat

Topics Earnings

Hims & Hers Massive Stock Drop Explained ↗

May 19, 2026

Raising debt increases the risk in Hims & Hers' stock.

Via The Motley Fool

Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering ↗

May 19, 2026

Hims & Hers Health (NYSE: HIMS) shares are trading flat in Tuesday's pre-market as traders continue to digest its convertible notes offering.

Via Benzinga

5 Revealing Analyst Questions From Hims & Hers Health’s Q1 Earnings Call

May 18, 2026

Hims & Hers Health’s first quarter was marked by a significant strategic pivot in its weight loss business, which management described as a move to prioritiz...

Via StockStory

Topics Earnings Economy

Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1

May 17, 2026

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer...

Via StockStory

Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign? ↗

May 15, 2026

Hims & Hers continues growing rapidly, but shrinking margins and rising costs are beginning to test the company's long-term profitability story.

Via The Motley Fool

Topics Artificial Intelligence

Is Hims and Hers Health Stock a Buy After Its Latest Dip? ↗

May 14, 2026

The stock continues to be very volatile.

Via The Motley Fool

1 Small-Cap Stock to Target This Week and 2 We Turn Down

May 14, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

A Hot CPI, Chips in Retreat, and $100 Oil: Tuesday's Market in Four Acts ↗

May 13, 2026

Via Chartmill

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery? ↗

May 12, 2026

Hims & Hers Health posted a Q1 FY2026 double miss, with an EPS loss of $0.40 and revenue of $608.1 million, sending shares down more than 12% after hours.

Via MarketBeat

Topics Intellectual Property Lawsuit

Why Hims & Hers Health Stock Just Crashed ↗

May 12, 2026

Hims & Hers is unshaken by its earnings miss, with management promising even faster sales growth this year.

Via The Motley Fool

Topics Earnings Lawsuit

Chips Push the S&P 500 to 7,400, Supercycle or the Last Act of a Bubble? ↗

May 12, 2026

Via Chartmill

Topics Stocks

HIMS Q1 Deep Dive: Strategic Pivot in Weight Loss and Margin Pressures Shape Outlook

May 12, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 mill...

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.